Differences Between Mesothelioma & Lung Cancer Development
Mesothelioma and lung cancer differ in location, growth pattern, treatment and other aspects. Lung cancer develops inside the lung space, while pleural mesothelioma develops on the lung’s outer lining. Mesothelioma can also develop in the lining of the abdomen, heart or testes. Asbestos exposure can cause a malignant mesothelioma tumor and lung cancer to develop.
Doctors diagnose roughly 2,800 cases of mesothelioma across all types of the rare asbestos-related cancer each year. Lung cancer is the second-most common cancer in the U.S. About 222,500 new cases are reported annually.
Mesothelioma begins as small nodules. They grow together into a sheath-like tumor around the organ. Lung cancer grows in larger, individual nodules with defined boundaries. Mesothelioma tends to remain near its origin. While lung cancer spreads or metastasizes early to other organs.
|Primary Cause||Asbestos Exposure||Smoking|
|Latency Period||20 to 60 Years||10 to 30 Years|
|Location||Lining of lungs, abdomen, heart or testes||Within the lung space|
|Tumor Characteristics||Small, widespread nodules||Large individual masses|
|5-Year Survival Rate||12%||26%|
Mesothelioma is often misconstrued as “mesothelioma lung cancer.” Asbestos exposure is the main cause. Tobacco use and environmental exposures, such as radon gas, cause most lung cancer cases, according to the American Lung Association. Each risk factor damages lung tissue. Combined, smoking and asbestos increase lung cancer risk at least fiftyfold.
Similarities Between Mesothelioma and Lung Cancer
Mesothelioma and lung cancer both develop decades after asbestos exposure. Both cancers can spread within months. Both also have comparable diagnostic procedures and treatment techniques.
Death rates by state for mesothelioma and lung cancer tend to correlate with each other. The five states with the most mesothelioma deaths also have the most lung cancer deaths.
Lung cancer and mesothelioma have overlapping symptoms. They both cause chest pain, coughing, difficulty breathing, fatigue and weight loss.
Lung cancer and mesothelioma differ in physical characteristics and nonasbestos risk factors.
Diagnosing Mesothelioma and Lung Cancer
Diagnosing mesothelioma and lung cancer requires a doctor to perform a biopsy. A CT or PET scan alone is unreliable for differentiating between lung cancer and mesothelioma. Biopsies may be performed via a bronchoscopy, needle biopsy or thoracoscopic surgery.
During a bronchoscopy, the doctor inserts a tiny camera down the throat and airways. It can detect abnormalities such as visible tumor growth. If the doctor finds irregular growth, they may collect a cell sample and test it for cancer.
A needle biopsy under local anesthesia involves placing a small needle into the tumor. An ultrasound machine or CT scan can visualize it. A thoracoscopic surgery collects a solid tissue sample using a small camera inserted between the ribs. Fluid buildup is suctioned out for testing but isn’t a reliable way to confirm a diagnosis.
Most patients with pleural mesothelioma will either show pleural thickening or effusion. Pleural thickening is extensive scarring in the chest cavity lining. Pleural effusion is fluid buildup in the chest cavity. Pleural thickening may not appear in lung cancer. Both exhibit pleural effusion.
Treating Mesothelioma and Lung Cancer
Mesothelioma and lung cancer treatment options depend on the cancer stage or how much the cancer has spread. Most treatment plans include some combination of surgery, radiation therapy or chemotherapy. Cisplatin is an effective chemotherapy drug for both lung cancer and mesothelioma.
If the cancer is localized to the lung area, surgery may be able to remove most or all of the tumor growth. In lung cancer, surgeons may remove the cancerous lobe of the lung via a lobectomy procedure. Mesothelioma surgeons might remove the pleural lining of the lungs in a pleurectomy and decortication.
A 2021 study found that certain types of radiation are less effective for lung cancer than mesothelioma. Focal radiotherapy is less effective for the treatment of lung cancer than mesothelioma. Clinical trials for both cancers offer immunotherapy, gene therapy, photodynamic therapy and cryotherapy.
Prognosis for Mesothelioma vs. Lung Cancer
The prognosis for mesothelioma and lung cancer differs for each patient based on several factors. Factors include an accurate diagnosis, cancer stage, general health and access to specialized care.
Survival rates for lung cancer and mesothelioma are similar after one year. About 42% of lung cancer patients and 39% of mesothelioma patients are alive one year after diagnosis. Yet, more lung cancer patients than mesothelioma patients survive at least five years.
The higher rate of lung cancer cases means more widespread access to specialized treatment centers and doctors. Mesothelioma is much rarer, leaving patients with fewer options to improve their prognosis.
Common Questions About Mesothelioma Vs. Lung Cancer
- Is mesothelioma a form of lung cancer?
Mesothelioma is not a form of lung cancer. Lung cancer develops inside the lungs. Mesothelioma develops on pleural tissue that surrounds the outside of the lungs, diaphragm and chest cavity. Both diseases can be caused by inhaling asbestos fibers. Mesothelioma can also develop in the peritoneum, which lines the abdominal cavity, and in rare cases, it can form in the testes or the lining of the heart.
- What are the warning signs of mesothelioma?
The earliest signs of mesothelioma include:
- Shortness of breath
- Chest pain or discomfort
- Persistent cough
- Fever or night sweats
- Nausea, vomiting or diarrhea
- Abdominal pain or swelling
- Lack of appetite or weight loss
- Should you see a mesothelioma specialist if you have asbestos-related lung cancer?
Pleural mesothelioma doctors have expertise in diagnosing and treating several asbestos-related diseases. They understand the complexities of lung cancer caused by asbestos. Top mesothelioma doctors can connect you with clinical research trials and specialized treatments.